{
  "meta": {
    "title": "51_Chronic_Kidney_Disease",
    "url": "https://brainandscalpel.vercel.app/51-chronic-kidney-disease-0bda645b.html",
    "scrapedAt": "2025-11-30T12:28:50.203Z"
  },
  "questions": [
    {
      "text": "Which of the following is not a risk factor for chronic kidney disease?",
      "choices": [
        {
          "id": 1,
          "text": "Childhood obesity"
        },
        {
          "id": 2,
          "text": "Diabetes mellitus"
        },
        {
          "id": 3,
          "text": "Family history of kidney disease"
        },
        {
          "id": 4,
          "text": "Large for gestational age at birth"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Small for gestational age</strong> (SGA) at birth is a <strong>risk factor</strong> for chronic kidney disease (<strong>CKD</strong>), not LGA.</p>\n<p>Important risk factors for CKD or chronic renal failure are:</p>\n<ul>\n<li>SGA</li>\n<li>Childhood <strong>obesity</strong></li>\n<li>Hypertension</li>\n<li><strong>Diabetes</strong> mellitus</li>\n<li>Autoimmune disease</li>\n<li><strong>Family history</strong> of kidney disease</li>\n<li>Previous episode of acute kidney injury</li>\n<li>Structural abnormalities of the urinary tract</li>\n<li>Autosomal dominant polycystic kidney disease</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1315",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common cause of chronic kidney disease?",
      "choices": [
        {
          "id": 1,
          "text": "Diabetic nephropathy"
        },
        {
          "id": 2,
          "text": "Glomerulonephritis"
        },
        {
          "id": 3,
          "text": "Hypertension"
        },
        {
          "id": 4,
          "text": "Adult polycystic kidney disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Diabetic nephropathy</strong> is the <strong>most common cause</strong> of chronic kidney disease (<strong>CKD</strong>).</p>\n<p>The leading causes&nbsp;of CKD in decreasing order of frequency are as follows:&nbsp;</p>\n<ul>\n<li data-listid=\"1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Diabetic nephropathy&nbsp;&nbsp;</li>\n<li data-listid=\"1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Glomerulonephritis&nbsp;</li>\n<li data-listid=\"1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Hypertension-associated CKD&nbsp;&nbsp;</li>\n<li data-listid=\"1\" data-aria-posinset=\"4\" data-aria-level=\"1\">ADPKD (Adult or autosomal dominant polycystic kidney disease)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1311",
      "difficulty": "easy"
    },
    {
      "text": "Patients with which of the following conditions are unlikely to develop chronic renal failure?",
      "choices": [
        {
          "id": 1,
          "text": "Post-streptococcal glomerulonephritis"
        },
        {
          "id": 2,
          "text": "Membranous glomerulonephritis"
        },
        {
          "id": 3,
          "text": "Membranoproliferative glomerulonephritis"
        },
        {
          "id": 4,
          "text": "Focal segmental glomerulosclerosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Post-streptococcal glomerulonephritis</strong> (PSGN) is least likely to cause chronic renal failure. It is&nbsp;a&nbsp;rapidly progressive condition and a cause of <strong>acute renal failure</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1320",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following parameters are used in the staging of chronic kidney disease?",
      "choices": [
        {
          "id": 1,
          "text": "Serum albumin and creatinine"
        },
        {
          "id": 2,
          "text": "Serum urea and creatinine"
        },
        {
          "id": 3,
          "text": "Urine albumin and eGFR"
        },
        {
          "id": 4,
          "text": "Serum creatinine and eGFR"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Stages of chronic kidney disease (CKD) are stratified by&nbsp;<strong>estimated</strong> <strong>GFR</strong>&nbsp;(eGFR) and degree of <strong>albuminuria</strong> in order to predict the risk of progression of CKD.&nbsp;Serum creatinine is not directly used in the staging of chronic kidney disease.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\"><strong>Stages of Chronic Kidney Disease based on GFR</strong></td>\n</tr>\n<tr>\n<td><strong>Stage</strong></td>\n<td>\n<p><strong>GFR</strong></p>\n<p><strong>(ml/min/1.73sq.mt)</strong></p>\n</td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>1</td>\n<td><span class=\"ILfuVd yZ8quc\">&ge;90</span></td>\n<td>Normal or increased GFR with other evidence of Kidney Damage</td>\n</tr>\n<tr>\n<td>2</td>\n<td>60-89</td>\n<td>Slight decrease in GFR, with other evidence of kidney damage</td>\n</tr>\n<tr>\n<td>3A</td>\n<td>45-59</td>\n<td rowspan=\"2\">Moderate decrease in GFR with or without other evidence of Kidney Damage</td>\n</tr>\n<tr>\n<td>3B</td>\n<td>30-44</td>\n</tr>\n<tr>\n<td>4</td>\n<td>15-29</td>\n<td>Severe decrease in GFR, with or without other evidence of kidney damage</td>\n</tr>\n<tr>\n<td>5</td>\n<td>&lt;15</td>\n<td>Established renal failure, also known as <strong>End-Stage Renal Disease</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d58da6d44999490aa2d4b3d9d43081eax1280x1836.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1604",
      "difficulty": "medium"
    },
    {
      "text": "In patients with chronic kidney disease, at which stage do the complications of kidney failure start appearing?",
      "choices": [
        {
          "id": 1,
          "text": "Stage 1"
        },
        {
          "id": 2,
          "text": "Stage 2"
        },
        {
          "id": 3,
          "text": "Stage 3-4"
        },
        {
          "id": 4,
          "text": "Stage 4-5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The features of kidney failure become prominent as the GFR progressively declines to&nbsp;<strong>stages 3 and 4.</strong>&nbsp;The following complications occur as a result of loss of kidney function:</p>\n<ul>\n<li>Volume overload</li>\n<li>Hyperkalemia</li>\n<li>Metabolic acidosis</li>\n<li>Hyperphosphatemia</li>\n<li>Mineral and bone disorders</li>\n<li>Hypertension</li>\n<li>Anemia</li>\n<li>Dyslipidemia</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1314",
      "difficulty": "medium"
    },
    {
      "text": "A 66-year-old woman is being evaluated for new-onset uremic encephalopathy. What is her GFR likely to be?",
      "choices": [
        {
          "id": 1,
          "text": "< 50 mL/min/1.73 m2"
        },
        {
          "id": 2,
          "text": "< 15 mL/min/1.73 m2"
        },
        {
          "id": 3,
          "text": "< 40 mL/min/1.73 m2"
        },
        {
          "id": 4,
          "text": "< 30 mL/min/1.73 m2"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Clinical features of <strong>uremia</strong> start to appear in patients with&nbsp;<strong>GFR</strong> <strong>&lt; 15 <span class=\"nowrap\">mL/min/1</span>.73 m</strong><sup><strong>2&nbsp;</strong></sup>or end-stage renal disease (<strong>ESRD</strong>). By this stage, renal clearance is severely impaired and the accumulation of uremic toxins leads to several complications including:</p>\n<ul>\n<li><strong>Uremic encephalopathy</strong></li>\n<li>Pruritus</li>\n<li>Malnutrition</li>\n<li>Anorexia, nausea, fatigue</li>\n<li>Platelet dysfunction</li>\n<li>Sexual dysfunction</li>\n<li>Pericarditis, pleuritis</li>\n<li>Peripheral neuropathy</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Stages of Chronic Kidney Disease</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td>\n<p><strong>GFR&nbsp;</strong><strong>(ml/ min/ 1.73 m<sup>2</sup>)</strong></p>\n</td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>1</td>\n<td><span class=\"ILfuVd yZ8quc\">&ge;90</span></td>\n<td>Normal or increased GFR with other evidence of Kidney Damage</td>\n</tr>\n<tr>\n<td>2</td>\n<td>60-89</td>\n<td>A slight decrease in GFR, with other evidence of kidney damage</td>\n</tr>\n<tr>\n<td>3A</td>\n<td>45-59</td>\n<td rowspan=\"2\">Moderate decrease in GFR with or without other evidence of Kidney Damage</td>\n</tr>\n<tr>\n<td>3B</td>\n<td>30-44</td>\n</tr>\n<tr>\n<td>4</td>\n<td>15-29</td>\n<td>Severe decrease in GFR, with or without other evidence of kidney damage</td>\n</tr>\n<tr>\n<td>5</td>\n<td>&lt;15</td>\n<td>End-stage renal disease</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1fbd695152d540608dff011721d1af58x1280x1836.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1367",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is incorrect about uremic syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "It occurs due to accumulation of toxins"
        },
        {
          "id": 2,
          "text": "There is loss of kidney function and hormone regulation"
        },
        {
          "id": 3,
          "text": "Systemic inflammation is seen"
        },
        {
          "id": 4,
          "text": "Can be eliminated by removing urea through intensive dialysis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Uremic syndrome</strong>&nbsp;cannot be eliminated by removing urea alone. It is a complex condition occurring due to the accumulation of <strong>multiple</strong>&nbsp;<strong>toxins</strong>.</p>\n<p>The pathophysiology of uremic syndrome&nbsp;involves the following:</p>\n<ul>\n<li>Accumulation of <strong>toxins&nbsp;</strong>(uremia) - urea, creatinine, other products of protein metabolism like urates, hippurates, polyamines, indoles.</li>\n<li>Loss of <strong>kidney function</strong> leading to fluid and electrolyte imbalance and hormone dysregulation.</li>\n<li>Progressive <strong>systemic inflammation</strong> with vascular and nutritional impairment.</li>\n</ul>\n<p>Clinical features secondary to loss of kidney function tend to develop in parallel with declining GFR. However the features of uremia and, hence, uremic syndrome, usually occur only in<strong> stage 5</strong> or <strong>ESRD</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1309",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man with CKD has been on dialysis for 3 months. He now presents with intense body pains and muscle pain. He suffered from 2 fractures over the last 2 months.  On evaluation, he was found to have decreased PTH levels and normal calcium levels. He has been regularly taking oral vitamin D and calcium tablets. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Osteomalacia"
        },
        {
          "id": 2,
          "text": "Adynamic bone disease"
        },
        {
          "id": 3,
          "text": "Osteitis fibrosa cystica"
        },
        {
          "id": 4,
          "text": "Tumoral calcinosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This clinical scenario in a <strong>CKD</strong> patient is suggestive of&nbsp;<strong>adynamic bone disease.</strong></p>\n<p>In CKD, metabolic bone disorders (renal osteodystrophy) can be of three types:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Osteitis fibrosa cystica</strong></td>\n<td><strong>Osteomalacia</strong></td>\n<td><strong>Adynamic bone disease</strong></td>\n</tr>\n<tr>\n<td>High bone turnover</td>\n<td>\n<p>Low bone turnover</p>\n</td>\n<td>\n<p>Low bone turnover</p>\n</td>\n</tr>\n<tr>\n<td>Renal calcium loss&nbsp;</td>\n<td>Decreased calcitriol formation leads to&nbsp;low calcium</td>\n<td>\n<p>It is an <strong>iatrogenic</strong> condition</p>\n<p>Increased intake of <strong>vitamin D</strong> or <strong>calcium-containing</strong> phosphate binders or dialysis.</p>\n</td>\n</tr>\n<tr>\n<td>High PTH occurs in response to low calcium (secondary hyperparathyroidism)</td>\n<td>\n<p>Low vitamin D leads to <strong>defective</strong> <strong>mineralization</strong></p>\n<p>Decreased calcium leads to a mild increase in PTH, which stimulates osteoblasts. Thus the <strong>bone volume</strong> is <strong>maintained</strong>.</p>\n</td>\n<td>\n<p>High vitamin D&nbsp; decreases PTH levels, which leads to <strong>decreased bone volume</strong>.</p>\n<p><strong>Mineralization</strong> is <strong>defective</strong> because of aluminium, which comes from dialysis.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Treatment:</strong></p>\n<p>Vitamin D + calcium</p>\n</td>\n<td>\n<p><strong>Treatment:</strong></p>\n<p>Vitamin D + calcium</p>\n</td>\n<td>\n<p><strong>Treatment:</strong></p>\n<p>Withdrawal of offending agent</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1323",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged woman with chronic kidney disease presents to the OPD  with exercise intolerance, fatigue, and shortness of breath.  On examination, she is found to have severe pallor.  Which of the following is least likely to be a cause for these findings?",
      "choices": [
        {
          "id": 1,
          "text": "Deficiency of erythropoietin"
        },
        {
          "id": 2,
          "text": "Iron deficiency"
        },
        {
          "id": 3,
          "text": "Hyperparathyroidism"
        },
        {
          "id": 4,
          "text": "Sickle cell anemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Sickle cell anemia is not a feature of chronic kidney disease (<strong>CKD</strong>).</p>\n<p>Common causes of <strong>anemia</strong> in CKD include:</p>\n<ul>\n<li><strong>Erythropoietin deficiency</strong></li>\n<li>Diminished red blood cell survival</li>\n<li>Bleeding diathesis</li>\n<li><strong>Iron deficiency</strong></li>\n<li>Vitamin B12 and folate deficiency</li>\n<li><strong>Hyperparathyroidism</strong> (due to bone marrow fibrosis)</li>\n<li>Hemoglobinopathy</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1342",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not seen in patients with chronic renal failure?",
      "choices": [
        {
          "id": 1,
          "text": "Peripheral neuropathy"
        },
        {
          "id": 2,
          "text": "Hyperthyroidism"
        },
        {
          "id": 3,
          "text": "Decreased vitamin D levels"
        },
        {
          "id": 4,
          "text": "Osteomalacia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Hyperthyroidism is not a feature of&nbsp;<strong>chronic</strong> <strong>renal failure</strong>.</p>\n<p>Option A: Peripheral neuropathy can occur secondary to uremia.</p>\n<p>Options C and D: In chronic renal failure, calcitriol (vitamin D3)&nbsp;production is decreased, leading to metabolic bone disease, which in turn leads to low serum calcium levels, secondary hyperparathyroidism, and osteomalacia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1348",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common neurological disorder seen in patients with CKD?",
      "choices": [
        {
          "id": 1,
          "text": "Dementia"
        },
        {
          "id": 2,
          "text": "Restless leg syndrome"
        },
        {
          "id": 3,
          "text": "Peripheral neuropathy"
        },
        {
          "id": 4,
          "text": "Encephalopathy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most common neurological disorder seen in patients with <strong>CKD</strong> is <strong>peripheral neuropathy</strong>.</p>\n<p>The various neuromuscular manifestations of CKD include:</p>\n<ul>\n<li>Memory and concentration impairment</li>\n<li>Dialysis <strong>dementia</strong> - due to aluminum intoxication</li>\n<li><strong>Restless leg syndrome</strong></li>\n<li>Peripheral neuropathy</li>\n<li>Hiccups</li>\n<li>Cramps</li>\n<li>Uremic <strong>encephalopathy</strong>\n<ul>\n<li>Confusion and lethargy</li>\n<li>Tremors</li>\n<li>Myoclonus</li>\n<li>Asterixis</li>\n<li>Seizures</li>\n<li>Coma</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1362",
      "difficulty": "medium"
    },
    {
      "text": "A 27-year-old woman goes to her family doctor as she is unable to fall asleep at night. She complains of tingling and crawling sensations over her legs at night. She also feels a strong urge to move her legs, which relieves the symptoms for a while. Which of the following is incorrect about this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Autosomal dominant inheritance"
        },
        {
          "id": 2,
          "text": "Associated with low serum ferritin"
        },
        {
          "id": 3,
          "text": "Most common cause is chronic kidney disease"
        },
        {
          "id": 4,
          "text": "Most common movement disorder in pregnancy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This clinical scenario is suggestive of <strong>restless legs syndrome</strong> (RLS) or <strong>Willis-Ekbom</strong> disease. Chronic kidney disease (CKD) is not<strong> </strong>the most common cause of this condition.   </p>\n<p>RLS is a neurological sleep disorder that can be primary or secondary. The <strong>primary</strong> form is more <strong>common</strong>. It shows <strong>autosomal dominant</strong> inheritance in most cases, but can be idiopathic. <strong>Secondary</strong> RLS is associated with the following:</p>\n<ul>\n<li><strong>Iron deficiency </strong></li>\n<li><strong>Pregnancy</strong> - most common movement disorder</li>\n<li>Peripheral neuropathy</li>\n<li>Diabetes mellitus</li>\n<li>CKD</li>\n<li>Parkinson's disease</li>\n<li>Multiple sclerosis</li>\n</ul>\n<p>It is characterized by an uncontrollable, <strong>restless</strong> urge to move the legs. It tends to worsen during periods of <strong>inactivity</strong> and at evening or <strong>night</strong>. It is accompanied by crawling, tingling or burning sensations. These symptoms show partial or complete <strong>improvement</strong> with <strong>movement</strong>. This cycle may continue for a while and result in <strong>insomnia</strong>.</p>\n<p>Primary RLS is managed by improving sleep hygiene and dopamine agonists (<strong>pramipexole</strong> or <strong>ropinirole</strong>) if symptoms persist. Iron supplements can also be given. In secondary RLS, the underlying cause must be treated. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1345",
      "difficulty": "medium"
    },
    {
      "text": "What is the most likely cause of convulsions in a patient with CKD?",
      "choices": [
        {
          "id": 1,
          "text": "Hypokalemia"
        },
        {
          "id": 2,
          "text": "Hyperkalemia"
        },
        {
          "id": 3,
          "text": "Hypercalcemia"
        },
        {
          "id": 4,
          "text": "Water intoxication"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most likely cause of convulsions in a patient with&nbsp;<strong>CKD</strong> is <strong>water intoxication</strong>. Volume overload in these patients as well as damage to the blood-brain barrier by uremic toxins causes <strong>cerebral edema</strong> and seizures.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1369",
      "difficulty": "hard"
    },
    {
      "text": "What is most common cause of mortality in patients with chronic kidney disease?",
      "choices": [
        {
          "id": 1,
          "text": "Cardiovascular disease"
        },
        {
          "id": 2,
          "text": "Sepsis"
        },
        {
          "id": 3,
          "text": "Uremia"
        },
        {
          "id": 4,
          "text": "Dialysis-related complications"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cardiovascular disease</strong> is the leading cause of morbidity and mortality in patients at every stage of <strong>CKD</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1326",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following would be elevated in patients with chronic kidney disease?",
      "choices": [
        {
          "id": 1,
          "text": "Fibrinogen"
        },
        {
          "id": 2,
          "text": "Fetuin"
        },
        {
          "id": 3,
          "text": "Albumin"
        },
        {
          "id": 4,
          "text": "Globulin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Chronic kidney disease (<strong>CKD</strong>) is associated with <strong>elevated</strong> levels of <strong>fibrinogen</strong>. </p>\n<p>CKD is a pro-inflammatory state characterized by altered levels of acute-phase reactants (<strong>APR</strong>) </p>\n<ul>\n<li><strong>Elevated</strong> levels of positive APR like <strong>CRP</strong> and <strong>fibrinogen</strong> (associated with high ESR).</li>\n<li><strong>Reduced</strong> levels of negative APR like <strong>albumin</strong> and <strong>fetuin</strong>.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1310",
      "difficulty": "medium"
    },
    {
      "text": "What is the predominant electrolyte abnormality seen in patients with advanced CKD?",
      "choices": [
        {
          "id": 1,
          "text": "Hyponatremia"
        },
        {
          "id": 2,
          "text": "Hypokalemia"
        },
        {
          "id": 3,
          "text": "Non-anion gap metabolic acidosis"
        },
        {
          "id": 4,
          "text": "High anion gap metabolic acidosis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>High anion gap metabolic acidosis</strong>&nbsp;is the predominant electrolyte abnormality in a patient with <strong>advanced CKD.</strong> In advanced CKD, impaired renal functioning causes decreased urinary excretion of acids. These&nbsp;retained organic acids&nbsp;result in a high anion gap.</p>\n<p>In<strong> early CKD</strong>, potassium retention is associated with bicarbonate loss. This gives rise to hyperchloremic&nbsp;metabolic acidosis with a&nbsp;<strong>normal anion gap</strong>&nbsp;in early CKD<strong>.</strong></p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">The following electrolyte abnormalities are seen in CKD:</p>\n<ul>\n<li><strong>Hyperkalemia</strong></li>\n<li>Hypocalcemia</li>\n<li>Hyperphosphatemia</li>\n<li>Hyperuricemia</li>\n<li>Hypermagnesemia</li>\n</ul>\n<p>Hypokalemia is uncommon in CKD and usually reflects markedly&nbsp;reduced dietary potassium intake, especially in association with excessive diuretic therapy or concurrent GI losses.</p>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1321",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is the most life-threatening manifestation of CKD?",
      "choices": [
        {
          "id": 1,
          "text": "Decreased GFR"
        },
        {
          "id": 2,
          "text": "Increased creatinine"
        },
        {
          "id": 3,
          "text": "Hyperkalemia"
        },
        {
          "id": 4,
          "text": "Proteinuria"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Of the given options, <strong>hyperkalemia</strong> is the <strong>most life-threatening</strong> complication of chronic kidney disease (CKD) as it can result in <strong>cardiac arrhythmias</strong> and <strong>sudden death.</strong></p>\n<p>CKD is staged based on&nbsp;<strong>declining</strong>&nbsp;glomerular filtration rate (<strong>GFR</strong>) and <strong>albuminuria</strong>. The various clinical manifestations occur due to loss of kidney function and <strong>accumulation</strong> of various uremic toxins (<strong>urea</strong>, <strong>creatinine</strong>, and other products of protein metabolism).</p>\n<p>Complications of declining kidney function include:</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<ul>\n<li>Volume overload</li>\n<li><strong>Hyperkalemia</strong></li>\n<li>Metabolic acidosis</li>\n<li>Hyperphosphatemia</li>\n<li>Mineral and bone disorders</li>\n<li>Hypertension</li>\n<li>Anemia</li>\n<li>Dyslipidemia</li>\n</ul>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6805",
      "difficulty": "medium"
    },
    {
      "text": "Patients with CKD have increased levels of all of the following except:",
      "choices": [
        {
          "id": 1,
          "text": "Insulin"
        },
        {
          "id": 2,
          "text": "PTH"
        },
        {
          "id": 3,
          "text": "Estrogen"
        },
        {
          "id": 4,
          "text": "FGF-23"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Serum <strong>estrogen</strong>&nbsp;levels are <strong>low</strong>&nbsp;in <strong>CKD</strong>&nbsp;patients. This leads to menstrual abnormalities and infertility.&nbsp;</p>\n<p>Option A: Plasma levels of insulin are<strong>&nbsp;</strong>elevated in CKD patients due to impaired clearance by the affected kidneys. Hence, insulin dose must be reduced in these patients.</p>\n<p>Option B: Elevated&nbsp;parathyroid hormone levels in CKD are secondary to derangements in the homeostasis of calcium, phosphate, and vitamin D.</p>\n<p>Option D: FGF-23 (fibroblast growth factor) is part of a family of phosphatonins that promotes renal phosphate excretion. The levels of this hormone increase early in the course of CKD.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1346",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents to the emergency with chest pain that is radiating to his shoulder, shortness of breath, and diaphoresis. He is a known case of chronic kidney disease. Which of the following investigations is best for diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Serial troponin levels over 6 hours"
        },
        {
          "id": 2,
          "text": "Troponin levels on admission and 1 hour later"
        },
        {
          "id": 3,
          "text": "Troponin and CK-MB levels at admission"
        },
        {
          "id": 4,
          "text": "Serial CK-MB levels over 6 hours"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This clinical scenario is suggestive of acute myocardial infarction (<strong>MI</strong>) in a patient with chronic kidney disease (<strong>CKD</strong>). A<strong> serial</strong>&nbsp;rise in cardiac <strong>troponin</strong> levels over <strong>3-6 hours</strong> following presentation is needed to make a diagnosis. An interval of 1-hour is not considered sufficient.&nbsp;</p>\n<p>Minor <strong>chronic elevations</strong> in serum <strong>troponins</strong> are commonly observed in patients with CKD even in the <strong>absence</strong> of <strong>cardiovascular</strong> disease. Hence, a single elevated troponin value in such patients cannot be used to diagnose MI.&nbsp;</p>\n<p><strong>CK-MB</strong>&nbsp;is far<strong> less sensitive</strong> and <strong>specific</strong> than troponins.&nbsp;Hence, it is not preferred.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1329",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is the most sensitive test to detect early diabetic nephropathy in a patient?",
      "choices": [
        {
          "id": 1,
          "text": "Urine albumin"
        },
        {
          "id": 2,
          "text": "Renal ultrasound"
        },
        {
          "id": 3,
          "text": "Creatinine clearance test"
        },
        {
          "id": 4,
          "text": "Serum BUN level"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Microalbuminuria</strong>&nbsp;is the <strong>most sensitive </strong>and earliest&nbsp;finding of diabetic nephropathy. It refers to urine albumin of <strong>30&ndash;300</strong> mg/24-hour urine.&nbsp;&nbsp;It is seen in the stage of&nbsp;incipient diabetic kidney disease.&nbsp;</p>\n<p>However, microalbuminuria is a very variable finding and is not required to diagnose nephropathy. <strong>Non-albuminuric</strong> diabetic nephropathy may occur in some patients and <strong>regression</strong> of albuminuria may be seen in type 1 diabetics.</p>\n<p>Diabetic nephropathy can be diagnosed if the following are satisfied:&nbsp;</p>\n<ul>\n<li><strong>Reduced</strong> <strong>GFR</strong> (&lt;&nbsp;60 mL/min/1.73 m<sup>2)&nbsp;</sup>with or without persistent albuminuria (&gt; 30 mg/day or urine PCR &gt; 30 mg/g)</li>\n<li>Long duration of diabetes or established diabetic retinopathy</li>\n<li>Other etiologies are ruled out</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6fc3e5ac8f754d6687b8fc57d9f17ad7x1280x1772.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1366",
      "difficulty": "medium"
    },
    {
      "text": "A patient with chronic kidney disease is found to have normal-sized kidneys on ultrasonography. Which of the following diagnoses is least likely?",
      "choices": [
        {
          "id": 1,
          "text": "Diabetic nephropathy"
        },
        {
          "id": 2,
          "text": "HIV nephropathy"
        },
        {
          "id": 3,
          "text": "Amyloidosis"
        },
        {
          "id": 4,
          "text": "Hypertensive nephropathy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Hypertensive nephropathy</strong>&nbsp;is unlikely in this patient as it usually presents with<strong> shrunken kidneys.</strong></p>\n<p>Longstanding CKD due to most causes results in&nbsp;bilaterally small kidneys. Causes of CKD&nbsp;with normal size kidneys are:</p>\n<ul>\n<li>Diabetic nephropathy (kidney size may be increased at the onset)</li>\n<li>Amyloidosis</li>\n<li>HIV nephropathy</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1368",
      "difficulty": "hard"
    },
    {
      "text": "A 65-year-old hypertensive patient has recently been diagnosed with stage 3 chronic kidney disease. According to the ESC 2018 guidelines, what target blood pressure would you choose for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "140/90 mm Hg"
        },
        {
          "id": 2,
          "text": "140/80 mm Hg"
        },
        {
          "id": 3,
          "text": "130/90mmHg"
        },
        {
          "id": 4,
          "text": "120/80 mmHg"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>According to the <strong>ESC 2018</strong> guidelines, the target blood pressure in <strong>hypertensive</strong> patients with <strong>CKD</strong> is <strong>&lt; 140/ 80</strong> mm Hg regardless of age.&nbsp;</p><hr><h3>Related Pearl: Target BP in hypertensive patients- European Society of Cardiology guidelines 2018</h3><table>\n<tbody>\n<tr>\n<td><strong>Age group</strong></td>\n<td><strong>Hypertension</strong></td>\n<td><strong>Coexisting diabetes</strong></td>\n<td><strong>Coexisting chronic kidney disease</strong></td>\n<td><strong>Coexisting coronary artery disease</strong></td>\n<td><strong>Coexisting stroke/ TIA</strong></td>\n</tr>\n<tr>\n<td>\n<p>18-65 years</p>\n<p>(Target systolic range- if tolerated)</p>\n</td>\n<td>\n<p class=\"p1\">120-130 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">120-130 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">130-140 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">120-130 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">120-130 mmHg</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>65-79 years</p>\n<p>(Target systolic range- if tolerated)</p>\n</td>\n<td>\n<p class=\"p1\">130-139 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">130-139 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">130-139 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">130-139 mmHg</p>\n</td>\n<td>\n<p class=\"p1\">130-139 mmHg</p>\n</td>\n</tr>\n<tr>\n<td>Office diastolic measurement</td>\n<td>70-79mmHg</td>\n<td>70-79mmHg</td>\n<td>70-79mmHg</td>\n<td>&nbsp;70-79mmHg</td>\n<td>&nbsp;70-79mmHg</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1328",
      "difficulty": "hard"
    },
    {
      "text": "A 50-year-old man who has been on dialysis for 2 years presents with bone pain and bowing of legs. Further evaluation reveals hyperparathyroidism and hyperphosphatemia. What is the initial treatment of choice in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Sevelamer"
        },
        {
          "id": 2,
          "text": "Cinacalcet"
        },
        {
          "id": 3,
          "text": "Pamidronate"
        },
        {
          "id": 4,
          "text": "Calcitriol"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This clinical scenario is suggestive of <strong>secondary hyperparathyroidism</strong> (HPT) and<strong> hyperphosphatemia </strong>in a patient with CKD. <strong data-stringify-type=\"bold\">Sevelamer </strong>is the best<strong> initial</strong> treatment for this patient. It is a <strong>phosphate binder</strong> that reduces the absorption of phosphate from the gastrointestinal tract.</p>\n<p>Other phosphate binders that can be used include:</p>\n<ul>\n<li>Calcium containing\n<ul>\n<li>Calcium acetate</li>\n<li>Calcium carbonate</li>\n</ul>\n</li>\n<li>Non-calcium containing\n<ul>\n<li>Sevelamer</li>\n<li>Lanthanum</li>\n</ul>\n</li>\n</ul>\n<p><strong>Calcitriol</strong> and <strong>cinacalcet</strong> are used to decrease PTH levels in <strong>secondary hyperparathyroidism</strong>. However, they also cause <strong>increased</strong> serum <strong>phosphate</strong> levels. Hence, they should not be given as initial treatment in patients with hyperphosphatemia.</p>\n<p>Bisphosphonates like <strong>pamidronate</strong> are used in the treatment of <strong>primary</strong> <strong>hyperparathyroidism</strong>.</p><p>World Kidney Day is a global health event celebrated annually on the 2nd Thursday in March since 2006. This year, on <strong>March 14</strong>, the theme is <strong>\"Kidney Health for All: Advancing equitable access to care and optimal medication practice.\"</strong> The focus is on overcoming barriers like gaps in early diagnosis, limited healthcare coverage, low awareness among healthcare workers, and challenges in medication accessibility and cost. The goal is to promote awareness about the vital role of kidneys and address issues to ensure optimal kidney care worldwide.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1325",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most appropriate definitive treatment for anemia in patients with chronic kidney disease?",
      "choices": [
        {
          "id": 1,
          "text": "IV iron sucrose"
        },
        {
          "id": 2,
          "text": "Darbepoetin"
        },
        {
          "id": 3,
          "text": "Blood transfusion"
        },
        {
          "id": 4,
          "text": "Oral iron supplements"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Anemia</strong> in patients with&nbsp;chronic kidney disease (<strong>CKD</strong>)&nbsp;is primarily due to decreased erythropoietin production. Hence, human recombinant erythropoietin (EPO) such as&nbsp;<strong>darbepoetin</strong> is the most appropriate treatment and is considered the <strong>mainstay</strong>.</p>\n<p class=\"p2\">However, an <strong>optimal response</strong> to treatment with EPO occurs only <strong>when iron stores</strong>&nbsp;are <strong>adequate</strong>. Hence, iron supplements (oral or IV) must be given first to ensure the effectiveness of EPO therapy.&nbsp;</p>\n<p>Other treatment options for anemia in CKD are:</p>\n<ul>\n<li>Vitamin B<sub>12</sub> and folate supplementation</li>\n<li>Blood transfusion - in severe anemia and failure to EPO therapy</li>\n</ul><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;The FDA recently apporved Daprodustat as the first oral treatment for anemia caused by CKD for adults who have been receiving dialysis for at least four months. The drug acts by ncreasing erythropoietin levels.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:829,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\">The FDA recently apporved <strong>Daprodustat</strong> as the first oral treatment for anemia caused by CKD for adults who have been receiving dialysis for at least four months. The drug acts by increasing erythropoietin levels.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1344",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following should not be used in a patient with CKD?",
      "choices": [
        {
          "id": 1,
          "text": "Ramipril"
        },
        {
          "id": 2,
          "text": "Diclofenac"
        },
        {
          "id": 3,
          "text": "Loop diuretics"
        },
        {
          "id": 4,
          "text": "Insulin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Diclofenac</strong> should not be used in a patient with CKD as it is&nbsp;<strong>nephrotoxic</strong>.</p>\n<p>Renal blood flow is regulated by prostaglandin E2. Aspirin, diclofenac and other NSAIDs <strong>inhibit cyclooxygenase.</strong>&nbsp;This decreases <strong>prostaglandin E2</strong> concentration, thereby causing a reduction in blood flow and GFR.&nbsp;</p>\n<p>Nephrotoxic drugs include the following:</p>\n<ul>\n<li>NSAIDs</li>\n<li>Antifungals (amphotericin B)</li>\n<li>Antibiotics\n<ul>\n<li>Aminoglycosides</li>\n<li>Vancomycin</li>\n<li>Cephalosporins</li>\n<li>Sulfonamides</li>\n<li>Streptomycin</li>\n</ul>\n</li>\n<li>Antivirals\n<ul>\n<li>Acyclovir</li>\n<li>Foscarnet</li>\n</ul>\n</li>\n<li>Chemotherapy drugs\n<ul>\n<li>Methotrexate</li>\n<li>Platins</li>\n</ul>\n</li>\n<li>Immunosuppressants (cyclosporine)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1364",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old man with type 2 diabetes has developed stage 4 CKD secondary to diabetic nephropathy.  He currently takes insulin for his diabetes. What changes need to be made to his regimen?",
      "choices": [
        {
          "id": 1,
          "text": "No adjustment required"
        },
        {
          "id": 2,
          "text": "Decreased insulin dose"
        },
        {
          "id": 3,
          "text": "Increased insulin dose"
        },
        {
          "id": 4,
          "text": "Add DPP 4 inhibitor"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In <strong>CKD</strong> patients with <strong>diabetes</strong>, the dose of <strong>insulin</strong> must be <strong>reduced</strong>.</p>\n<p>In CKD patients, the plasma levels of<strong>&nbsp;</strong>insulin are elevated due to&nbsp;diminished renal degradation of insulin by the impaired kidney. This <strong>impaired&nbsp;renal</strong> <strong>clearance</strong> of insulin can lead to&nbsp;<strong>hypoglycemia</strong>. Hence, the dose of insulin must be reduced to prevent this.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1361",
      "difficulty": "medium"
    }
  ]
}